Breaking News Instant updates and real-time market news.

OLN

Olin

$18.31

-0.04 (-0.22%)

07:06
11/04/19
11/04
07:06
11/04/19
07:06

Olin downgraded to Hold from Buy at SunTrust

SunTrust analyst James Sheehan downgraded Olin to Hold from Buy with a price target of $19, down from $27, after its Q3 earnings miss and a cut in its FY19 guidance. The analyst says his expected strengthening in supply/demand for chlor-alkali did not materialize since "chlorine demand has outpaced caustic soda demand", which is the reverse of the typical trend during economic slowdown. Sheehan adds that the high chlor-alkali operating rates are likely to be sustainable next year, which should prevent caustic soda prices from gaining traction. The analyst further notes that at current levels, he sees the upside and downside risks on the stock as "fairly balanced".

  • 12

    Nov

OLN Olin
$18.31

-0.04 (-0.22%)

10/15/19
WELS
10/15/19
INITIATION
Target $21
WELS
Market Perform
Olin initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Michael Sison initiated coverage of Olin with a Market Perform rating and $21 price target. The analyst contends that the company's commodity chemical portfolio is "attractive", but its near term pricing is not improving as fast as expected amid the weak overall demand environment. If the pricing improves however, Sison is positive on Olin's #1 global position in Chlor-Alkali with the lowest cost global footprint.
10/17/19
JPMS
10/17/19
DOWNGRADE
Target $18
JPMS
Neutral
Olin downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Olin to Neutral from Overweight with a $18 price target.
10/17/19
JPMS
10/17/19
DOWNGRADE
Target $19
JPMS
Neutral
JPMorgan downgrades Olin to Neutral on caustic soda concerns
JPMorgan analyst Jeffrey Zekauskas downgraded Olin (OLN) to Neutral from Overweight with an unchanged price target of $19. When the recession comes, it will be "less friendly" to caustic soda pricing and profitability than past downturns, Zekauskas tells investors in a research note. Further, in the current economic environment, a sharp housing contraction is unlikely relative to industrial demand, as is the possibility of a sharp counter-cyclical rise in caustic soda prices stemming from a supply/demand squeeze, adds the analyst. The risk/reward characteristics of Olin and Westlake Chemical (WLK) are then less favorable, he says. Zekauskas downgrades Olin to Neutral, matching his rating on Westlake.
11/04/19
RHCO
11/04/19
DOWNGRADE
Target $19
RHCO
Hold
Olin downgraded to Hold from Buy at SunTrust
SunTrust analyst James Sheehan downgraded Olin to Hold from Buy with a $19 price target.

TODAY'S FREE FLY STORIES

WST

West Pharmaceutical

$146.54

1.07 (0.74%)

06:06
12/12/19
12/12
06:06
12/12/19
06:06
Downgrade
West Pharmaceutical rating change  »

West Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHEF

Chefs' Warehouse

$35.51

-0.06 (-0.17%)

06:05
12/12/19
12/12
06:05
12/12/19
06:05
Initiation
Chefs' Warehouse initiated  »

Piper Jaffray starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OII

Oceaneering

$13.48

0.32 (2.43%)

06:03
12/12/19
12/12
06:03
12/12/19
06:03
Upgrade
Oceaneering rating change  »

Oceaneering upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYY

Sysco

$82.88

0.38 (0.46%)

06:03
12/12/19
12/12
06:03
12/12/19
06:03
Initiation
Sysco initiated  »

Sysco initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPWR

Monolithic Power

$169.05

4.15 (2.52%)

06:01
12/12/19
12/12
06:01
12/12/19
06:01
Initiation
Monolithic Power initiated  »

Rosenblatt starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$211.96

-3.88 (-1.80%)

06:01
12/12/19
12/12
06:01
12/12/19
06:01
Upgrade
Home Depot rating change  »

Home Depot upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

05:57
12/12/19
12/12
05:57
12/12/19
05:57
Downgrade
SeaSpine rating change  »

SeaSpine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$56.88

0.03 (0.05%)

05:56
12/12/19
12/12
05:56
12/12/19
05:56
Upgrade
Globus Medical rating change  »

Globus Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

05:56
12/12/19
12/12
05:56
12/12/19
05:56
Downgrade
Glaukos rating change  »

Glaukos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$29.99

0.69 (2.35%)

05:55
12/12/19
12/12
05:55
12/12/19
05:55
Downgrade
Merit Medical rating change  »

Merit Medical downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWAV

ShockWave Medical

$41.84

1.41 (3.49%)

05:55
12/12/19
12/12
05:55
12/12/19
05:55
Upgrade
ShockWave Medical rating change  »

ShockWave Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$293.12

8.48 (2.98%)

, PZZA

Papa John's

$60.84

1.29 (2.17%)

05:55
12/12/19
12/12
05:55
12/12/19
05:55
Conference/Events
Stephens to hold a plane trip »

Restaurants Plane Trip…

DPZ

Domino's Pizza

$293.12

8.48 (2.98%)

PZZA

Papa John's

$60.84

1.29 (2.17%)

TXRH

Texas Roadhouse

$57.25

0.55 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

MPWR

Monolithic Power

$169.05

4.15 (2.52%)

05:47
12/12/19
12/12
05:47
12/12/19
05:47
Initiation
Monolithic Power initiated  »

Monolithic Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$18.21

0.6 (3.41%)

05:35
12/12/19
12/12
05:35
12/12/19
05:35
Initiation
Huya initiated  »

Huya initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMAB

Genmab

, AZN

AstraZeneca

$48.19

0.23 (0.48%)

05:32
12/12/19
12/12
05:32
12/12/19
05:32
Downgrade
Genmab, AstraZeneca, Roche rating change  »

Genmab downgraded to Hold…

GMAB

Genmab

AZN

AstraZeneca

$48.19

0.23 (0.48%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

  • 17

    Dec

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

, MCK

McKesson

$143.40

0.59 (0.41%)

05:31
12/12/19
12/12
05:31
12/12/19
05:31
Hot Stocks
Walgreens Boots Alliance, McKesson create German wholesale JV »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

MCK

McKesson

$143.40

0.59 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MTUAY

MTU Aero Engines

$0.00

(0.00%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Downgrade
MTU Aero Engines rating change  »

MTU Aero Engines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, HALO

Halozyme

$18.74

-0.46 (-2.40%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Hot Stocks
Genentech says Phase III FeDeriCa study met primary endpoint »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

HALO

Halozyme

$18.74

-0.46 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

OEZVY

Verbund

$0.00

(0.00%)

05:28
12/12/19
12/12
05:28
12/12/19
05:28
Upgrade
Verbund rating change  »

Verbund upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALV

Autoliv

$83.17

0.81 (0.98%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Autoliv rating change  »

Autoliv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AMGN

Amgen

$233.96

0.14 (0.06%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Hot Stocks
Amgen, UCB announce EC approval of EVENITY »

Amgen and UCB announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$28.03

0.14 (0.50%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
BMW rating change  »

BMW upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$49.60

0.43 (0.87%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
Charles Schwab rating change  »

Charles Schwab upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVKIF

Evonik

$0.00

(0.00%)

05:22
12/12/19
12/12
05:22
12/12/19
05:22
Upgrade
Evonik rating change  »

Evonik upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.